Related Experiment Video
Updated: Jun 29, 2025

10:21
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
427
Sjögren's syndrome and Parkinson's Disease: A bidirectional two-sample Mendelian randomization study
Xin Cai1, Zexu Jin1, Shaoqin Zhang2
1Department of Rheumatology, The First People's Hospital of Guiyang, Guiyang, Guizhou Province, China.
Plos One
|April 3, 2024
Summary
This study found no causal link between Sjögren's syndrome (SS) and Parkinson's Disease (PD). Mendelian randomization analysis did not support SS increasing PD risk, contrary to some observational findings.
Area of Science:
- Neurology
- Immunology
- Genetics
Background:
- Observational studies suggest an association between Sjögren's syndrome (SS) and an increased risk of Parkinson's Disease (PD).
- The causal relationship between SS and PD remains unclear.
- This study aimed to clarify the potential causal impact of SS on PD risk.
Purpose of the Study:
- To investigate the causal effect of Sjögren's syndrome on the risk of developing Parkinson's Disease.
- To examine the potential causal effect of Parkinson's Disease on the risk of developing Sjögren's syndrome.
- To utilize Mendelian randomization to assess genetic predispositions for both conditions.
Main Methods:
- Bidirectional Mendelian randomization (MR) analysis was performed.
- Genome-wide association studies (GWAS) data were used.
- Inverse-variance weighted (IVW) method was the primary analysis, with MR-Egger, weighted median, and MR-PRESSO used for sensitivity analyses.
Main Results:
- No significant causal association was found between Sjögren's syndrome and Parkinson's Disease using the IVW method (OR = 1.00, P = 0.95).
- Reverse MR analysis also showed no significant causal relationship between Parkinson's Disease and Sjögren's syndrome (OR = 0.98, P = 0.73).
- Sensitivity analyses indicated no significant horizontal pleiotropy, supporting the robustness of the findings.
Conclusions:
- This Mendelian randomization study does not support a causal link between Sjögren's syndrome and an increased risk of Parkinson's Disease.
- The findings contrast with some previous observational studies.
- Further research is needed to understand the mechanisms behind the observed associations in observational data.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K

